Rotavirus vaccine, live, oral, tetravalent (RotaShield). 1999

C Hochwald, and L Kivela
Hermann Children's Hospital, Houston, TX, USA.

Nearly every child will experience rotavirus infection before the age of 5. Rotavirus is transmitted via a fecal-oral route. Because the virus is shed in the stool, outbreaks of rotavirus infection can occur on the pediatric hospital wards and in day care centers. Ingestion of the rotavirus particles infects the cells in the villi of the small intestine. Copious amounts of watery diarrhea will occur after an incubation period of 1 to 2 days. If untreated, children less than 2 years of age can die from the resulting severe gastroenteritis dehydration. In the United States, rotavirus infection peaks during the winter months and is the cause of most cases of diarrhea in infants and young children. Rotavirus infection accounts for approximately 70,000 hospital admissions for diarrhea and as many as 100 deaths each year in the United States. World wide rotavirus infection accounts for approximately 1 million deaths each year (Bass, 1996). Although the number of deaths from rotaviral disease in the United States is low, parents frequently miss work, have to arrange for alternative care, travel to the doctor, give their child oral rehydrating solutions, and buy extra diapers. Implementation of mass vaccination with RotaShield will significantly reduce these indirect costs.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D012400 Rotavirus Infections Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice. Infection, Rotavirus,Infections, Rotavirus,Rotavirus Infection
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D022243 Rotavirus Vaccines Vaccines or candidate vaccines used to prevent infection with ROTAVIRUS. Rotavirus Vaccine,Vaccine, Rotavirus,Vaccines, Rotavirus

Related Publications

C Hochwald, and L Kivela
January 1999, The Annals of pharmacotherapy,
C Hochwald, and L Kivela
December 2007, Clinical therapeutics,
C Hochwald, and L Kivela
November 1987, Lancet (London, England),
C Hochwald, and L Kivela
January 2006, Pediatric annals,
C Hochwald, and L Kivela
July 1986, Lancet (London, England),
C Hochwald, and L Kivela
August 1991, American journal of diseases of children (1960),
C Hochwald, and L Kivela
May 2000, Vaccine,
C Hochwald, and L Kivela
May 1993, Clinical and experimental immunology,
C Hochwald, and L Kivela
July 1994, The Pediatric infectious disease journal,
Copied contents to your clipboard!